ARTICLE | Clinical News
Cygnus Therapeutic Systems regulatory update
July 25, 1994 7:00 AM UTC
The Redwood City, Calif., company said the FDA accepted Warner-Lambert's NDA for CYGN's Estradiol 7-day transdermal hormone replacement therapy patch. The NDA was resubmitted by Warner-Lambert in May ...